LITHIUM CARBONATE

Search structure
Trade Names:
Synonyms:
Status: Approved (1970)
Entry Type: Small molecule
Molecule Category: Salt
UNII: 2BMD2GNA4V
Parent Compound: LITHIUM

Structure
InChI Key XGZVUEUWXADBQD-UHFFFAOYSA-L
Smile O=C([O-])[O-].[Li+].[Li+]
InChI
InChI=1S/CH2O3.2Li/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2

Physicochemical Descriptors

Property Name Value
Molecular Formula CLi2O3
Molecular Weight 73.89
AlogP None
Hydrogen Bond Acceptor None
Hydrogen Bond Donor None
Number of Rotational Bond None
Polar Surface Area None
Molecular species None
Aromatic Rings None
Heavy Atoms None

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Glycogen synthase kinase-3 inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Depressive Disorder 4 D003866 ClinicalTrials
Dementia 3 D003704 ClinicalTrials
Amyotrophic Lateral Sclerosis 3 D000690 ClinicalTrials
Schizophrenia 3 D012559 ClinicalTrials
Alcoholism 3 D000437 ClinicalTrials
Depressive Disorder, Treatment-Resistant 3 D061218 ClinicalTrials
Stroke 3 D020521 ClinicalTrials
Conduct Disorder 3 D019955 ClinicalTrials
Carotid Artery Diseases 3 D002340 ClinicalTrials
Anxiety 3 D001007 ClinicalTrials
Child Development Disorders, Pervasive 3 D002659 ClinicalTrials
Aggression 3 D000374 ClinicalTrials
Carotid Stenosis 3 D016893 ClinicalTrials
Neutropenia 3 D009503 ClinicalTrials
Frontotemporal Dementia 2 D057180 ClinicalTrials
Machado-Joseph Disease 2 D017827 ClinicalTrials
Multiple System Atrophy 2 D019578 ClinicalTrials
Fractures, Bone 2 D050723 ClinicalTrials
Spinal Cord Injuries 2 D013119 ClinicalTrials
Neuroendocrine Tumors 2 D018358 ClinicalTrials
Brain Neoplasms 2 D001932 ClinicalTrials
Carcinoma, Medullary 2 D018276 ClinicalTrials
Thyroid Neoplasms 2 D013964 ClinicalTrials
Alzheimer Disease 2 D000544 ClinicalTrials
Huntington Disease 2 D006816 ClinicalTrials
Spinocerebellar Ataxias 2 D020754 ClinicalTrials
Spinocerebellar Ataxias 2 D020754 ClinicalTrials
Adenomatous Polyposis Coli 2 D011125 ClinicalTrials
Spinal Cord Injuries 2 D013119 ClinicalTrials
Post-Acute COVID-19 Syndrome 2 D000094024 ClinicalTrials
Niemann-Pick Disease, Type C 1 D052556 ClinicalTrials
Supranuclear Palsy, Progressive 1 D013494 ClinicalTrials
Corticobasal Degeneration 1 D000088282 ClinicalTrials
Brain Concussion 1 D001924 ClinicalTrials
Multiple Sclerosis 1 D009103 ClinicalTrials
Parkinson Disease 1 D010300 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 1 D064129 ClinicalTrials
Central Nervous System Neoplasms 1 D016543 ClinicalTrials
Small Cell Lung Carcinoma 1 D055752 ClinicalTrials

Related Entries

Parent

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Nervous system disorders
18.57
Psychiatric disorders
12.89
Injury, poisoning and procedural complications
10.84
General disorders and administration site conditions
8.7
Renal and urinary disorders
7.37
Metabolism and nutrition disorders
6.93
Investigations
4.97
Cardiac disorders
4.02
Endocrine disorders
3.74
Gastrointestinal disorders
3.69
Musculoskeletal and connective tissue disorders
3.18
Respiratory, thoracic and mediastinal disorders
2.88
Vascular disorders
2.32

Cross References

Resources Reference
CAS NUMBER 554-13-2
ChEBI 6504
ChEMBL CHEMBL1200826
DrugBank DB14509
EPA CompTox DTXSID1023784
FDA SRS 2BMD2GNA4V
KEGG C07964
PubChem 516884
SureChEMBL SCHEMBL25389
CONTENTS